Mingyizhudao.com, a surgery-booking platform, announced on Wednesday that it has completed a Series B round of financing worth RMB 150 million (USD 23 million) led by INC and Hanfor Holdings, followed by Fosun Pharma, Banyan Capital and Zhen Fund.
Sophia Zheng, INC’s CEO, explained why they invested in the platform. She said the platform has a team that works well together and an ability to execute ideas efficiently, according to the tech news website Chuangkem.com.
Launched in October 2014, the platform aims to help patients schedule appointments with renowned doctors. More than 20,000 chief physicians and associate chief physicians from Class A hospitals have registered on the platform, and over 10,000 patients have completed surgery with the platform’s help, the company’s CEO Su Shu said at a press conference on Wednesday.
At the press conference, the platform also announced that it will work with volunteer physicians, charitable organizations and public hospitals to provide a set number of surgeries free of charge to patients who can’t afford surgery fees.
“Our goal in 2016 is to help more than 10,000 patients get surgery every month,” said Su.
Apart from this round of financing, the platform finished an angel financing round of RMB five million led by Zhen Fund in May 2015. In October 2015, the platform closed a RMB 60 million round Series A financing round led by Fosun Pharma and followed by Banyan Capital and Zhen Fund.
(Top photo from online.xywy.com.)